39703b05 F774 4aed 9792 000a61531553 01
Topiramate Tablet, Film Coated
Product Images NDC 70518-0233
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 70518-0233). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
39703b05 F774 4aed 9792 000a61531553 02
This is a graph that displays the cumulative rates for time to the first seizure. The data is comparing two groups, one group of 234 individuals taking 50mg/day of topiramate and the other group of 236 individuals taking 400mg/day of topiramate. The graph shows that the two groups have significantly different rates of experiencing a seizure, with a p-value of 0.0002. The x-axis displays the time in days and ranges from 0 to 400, while the y-axis shows the cumulative rate percentage and ranges from 0 to 100.*
39703b05 F774 4aed 9792 000a61531553 03
This text appears to be a table showing the change in average monthly migraine period rate from baseline to double-blind phase across different treatment groups (placebo, topiramate at 50mg/day, 100mg/day, and 200mg/day). The table includes counts of participants in each group (N values) and a significant difference in migraine rate is noted with asterisks denoting the level of significance. A description of what study this table is referring to and any further context is not available.*
Remedy_label (Remedy Label)
This is a medication called Topiramate that comes in the form of 25 mg tablets packaged by Remedy Repack Inc. Its National Drug Code (NDC) is 70518-0233-00 and it is manufactured by Zydus Pharm in Pennington, NJ. The medication should be kept out of reach of children and stored at a temperature between 20-25°C (68-77°F) with excursions permitted of 15-30°C (59-86°F). The prescription must be used according to instructions provided in the package insert.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
